Literature DB >> 9046945

Parvovirus B19 in human disease.

K E Brown1, N S Young.   

Abstract

Parvovirus B19, the only known human pathogenic parvovirus, is associated with a wide range of disease manifestations. In healthy individuals, the major presentation of B19 infection is erythema infectiosum. In patients with underlying hemolytic disorders, infection is the primary cause of transient aplastic crisis. In immunosuppressed patients, persistent infection may develop that presents as pure red cell aplasia and chronic anemia. In utero infection may result in hydrops fetalis or congenital anemia. Diagnosis is based on examination of bone marrow and virologic studies. Much is known of the pathophysiology of the virus, and studies are in progress to develop a vaccine to prevent this widespread infection.

Entities:  

Mesh:

Year:  1997        PMID: 9046945     DOI: 10.1146/annurev.med.48.1.59

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  17 in total

1.  Parvovirus infection mimicking systemic lupus erythematosus.

Authors:  Mohan Cooray; Joshua J Manolakos; Douglas S Wright; Shariq Haider; Ameen Patel
Journal:  CMAJ       Date:  2013-08-26       Impact factor: 8.262

2.  [Outbreak of infectious erythema at a urban health center].

Authors:  A I Revilla Grande; T Carro García; M Sánchez de Dios; M J Galán Calvo; T Nebreda Mayoral
Journal:  Aten Primaria       Date:  2000 Jul-Aug       Impact factor: 1.137

3.  New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections.

Authors:  T C Harder; M Hufnagel; K Zahn; K Beutel; H J Schmitt; U Ullmann; P Rautenberg
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.

Authors:  Wei Zou; Zekun Wang; Min Xiong; Aaron Yun Chen; Peng Xu; Safder S Ganaie; Yomna Badawi; Steve Kleiboeker; Hiroshi Nishimune; Shui Qing Ye; Jianming Qiu
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 5.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient.

Authors:  Ilmay Bilge; Banu Sadikoğlu; Sevinç Emre; Aydan Sirin; Kubilay Aydin; Burak Tatli
Journal:  Pediatr Nephrol       Date:  2005-01-27       Impact factor: 3.714

7.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

8.  The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.

Authors:  Xuefeng Deng; Yanming Dong; Qianhui Yi; Yu Huang; Dan Zhao; Yongbo Yang; Peter Tijssen; Jianming Qiu; Kaiyu Liu; Yi Li
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

9.  Extramedullary hematopoiesis in hereditary spherocytosis deficient in ankyrin: a case report.

Authors:  E Granjo; R Bauerle; R Sampaio; P Manata; N Torres; A Quintanilha
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

10.  Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia.

Authors:  Shigeki Ito; Tatsuo Oyake; Toshiyuki Uchiyama; Takeshi Sugawara; Kazunori Murai; Yoji Ishida
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.